Skip to main content Skip to main navigation menu Skip to site footer

Diagnostic and predictive value of hematological parameters of COVID-19 patients: a retrospective study

  • Estie Ludi Kiriwenno ,
  • Yulia Nadar Indrasari ,


Abstract

Link of Video Abstract: https://youtu.be/K2R3dfdvi20

Background: Simple, cost-effective, and practical laboratory indicators are required to diagnose and evaluate COVID-19 disease severity. This study assessed the diagnostic value and predictor of severity and outcome parameters of NLR, d-NLR, MLR, PLR, and ALC in COVID-19 patients.

Methods: A retrospective study used medical record data from 100 COVID-19 patients from November 2020 to March 2021. SPSS version 22 was used to analyze the data. The severity of COVID-19 was predicted using a ROC curve. Kaplan-Meier analysis was employed to evaluate the ability of various inflammatory markers to predict COVID-19 prognosis. A multivariate analysis with logistic regression was conducted to assess the ability of an independent predictor of COVID-19 severity. A p-value of <0.05 was considered significant.

Results: ALC values were lower in the severe-critical COVID-19 group, whereas NLR, d-NLR, MLR, and PLR values were higher. The NLR, d-NLR, and ALC parameters had sufficient accuracy, whereas the MLR and PLR parameters had low accuracy. NLR, d-NLR, MLR, PLR, and ALC had optimal cut-off values of 7.865, 4.82, 0.455, 235.000, and 0.895, respectively. The multivariate odds ratio for ALC was 7.348 (95% CI = 1.914-28.214; p = 0.004). Kaplan-Meier analysis revealed differences in survival time based on the optimal NLR, MLR, d-NLR, and ALC cut-offs obtained.

Conclusion: NLR, d-NLR, MLR, PLR, and ALC are all potential predictors of COVID-19 severity and prognosis. ALC is a reliable predictor of COVID-19 severity.

Keywords: COVID-19 Infectious disease ALC d-NLR NLR

References

  1. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of pharmaceutical analysis. 2020;10(2):102-108.
  2. Kusuma VP, Ardiany D. The Pathophysiology and Outcomes of Diabetic Patients with Coronavirus Disease 2019 (COVID-19). Biomolecular and Health Science Journal. 2021;4(2):131-136.
  3. Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules (Basel, Switzerland). 2020;25(23):5725.
  4. Sutadji JC, Widodo ADW, Indiastuti DN. Mortality Comparison of Using Anti Interleukin-6 Therapy and Using Standard Treatment in Severe Covid-19. Folia Medica Indonesiana. 2021;57(2):158-165.
  5. Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L, et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. Journal of clinical laboratory analysis. 2020;34(10):e23475.
  6. Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110-114.
  7. Simadibrata DM, Calvin J, Wijaya AD, Ibrahim NAA. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med. 2021;42:60-69.
  8. Suryananda TD, Yudhawati R. Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling. Ann Med Surg (Lond). 2021;69:102673.
  9. Saputra GNR, Yudhawati R, Fitriah M. Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study. nn Med Surg (Lond). 2022;74(1):103303.
  10. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8(1):152.
  11. Ueyama H, Kuno T, Takagi H, Krishnamoorthy P, Vengrenyuk Y, Sharma SK, et al. Gender Difference Is Associated With Severity of Coronavirus Disease 2019 Infection: An Insight From a Meta-Analysis. Critical Care Explorations. 2020;2(6):e0148.
  12. Hu D, Lou X, Meng N, Li Z, Teng Y, Zou Y, et al. Influence of age and gender on the epidemic of COVID-19 : Evidence from 177 countries and territories-an exploratory, ecological study. Wiener Klinische Wochenschrift. 2021;133(7-8):321-330.
  13. Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex. Journal of Medical Virology. 2020;92(10):2050-2054.
  14. Liu R, Zhao L, Cheng X, Han H, Li C, Li D, et al. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study. Liver Int. 2021;41(4):720-730.
  15. Bae S, Kim SR, Kim MN, Shim WJ, Park SM. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart (British Cardiac Society). 2021;107(5):373-380.
  16. Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms. Scandinavian journal of immunology. 2021;93(2):e12967.
  17. Illg Z, Muller G, Mueller M, Nippert J, Allen B. Analysis of absolute lymphocyte count in patients with COVID-19. The American journal of emergency medicine. 2021;46:16-19.
  18. Ciccullo A, Borghetti A, Zileri Dal Verme L, Tosoni A, Lombardi F, Garcovich M, et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. International journal of antimicrobial agents. 2020;56(2):106017.
  19. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020;84(1):106504.
  20. Vafadar Moradi E, Teimouri A, Rezaee R, Morovatdar N, Foroughian M, Layegh P, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. The American journal of emergency medicine. 2021;40(2):11-14.
  21. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. Journal of medical virology. 2020;92(9):1533-1541.
  22. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP). 2011;11(4):445-452.
  23. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert review of cardiovascular therapy. 2013;11(1):55-59.
  24. Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234(1):206-213.
  25. Rantam FA, Prakoeswa CRS, Tinduh D et al. Characterization of SARS-CoV-2 East Java isolate, Indonesia. F1000Research. 2021;10(480):1-17
  26. Visuddho V, Subagjo A, Setyoningrum RA, Rosyid AN. RESEARCH ARTICLE Survival analysis and outcome prediction of COVID-19 patients: a retrospective observational study from tertiary referral hospital in Indonesia. Tropical Biomedicine. 2022;39(2):239-246.
  27. Prabawa IMY, Silakarma D, Prabawa IPY, Manuaba IBAP. Physical rehabilitation therapy for long covid-19 patient with respiratory sequelae: A systematic review. Open Access Macedonian Journal of Medical Sciences. 2022;10(F):468-474.
  28. Pranata S, Vranada A, Armiyati Y, Samiasih A, Aisah S, Kurnia A, Sasmito P, et al. Inflammatory markers for predicting severity, mortality, and need for intensive care treatments of a patient infected with covid-19: a scoping review. Bali Medical Journal. 2023;12(1):324–330.
  29. Kumbara CIYK, Wibawa IDN, Somayana IG, Suryadarma IGA, Mariadi IK. Diagnostic performance of APRI, RPR, FIB-4, GPR, AAR, and NLR in assessing the degree of liver fibrosis in patients with chronic hepatitis B. Indonesia Journal of Biomedical Science. 2020;14(2):122–127.
  30. Kalemci S, Sarıhan A, Zeybek A. Association between NLR and COVID-19. International Immunopharmacology. 2020;88:106917.
  31. Bedel C, Korkut M, Armağan HH. NLR, d-NLR and PLR can be affected by many factors. International Immunopharmacology. 2021;90:107154.

How to Cite

Kiriwenno, E. L., & Indrasari, Y. N. (2023). Diagnostic and predictive value of hematological parameters of COVID-19 patients: a retrospective study. Bali Medical Journal, 12(2), 1446–1450. https://doi.org/10.15562/bmj.v12i2.4253
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Estie Ludi Kiriwenno
Google Scholar
Pubmed
BMJ Journal

Yulia Nadar Indrasari
Google Scholar
Pubmed
BMJ Journal